University of Chicago

Verona Pharma plc entered into agreements that give the company access to as much as $650m in new debt and other financing, bringing its new cash potential to more than $1bn after starting the year w

Mydecine, JHU Expand Pact Focused Initially On Smoking Cessation Mydecine Innovations Group Inc. and Johns Hopkins University said on 18 August that they will undertake a five-year collaboration t

BridgeBio Pharma, Inc. employs a business model of acquiring rights to or partnering with academic and institutional research in monogenic diseases and genetic cancer indications, often forming singl

Pyxis Oncology unveiled a $152m series B venture capital round on 30 March that will fund advancement of three preclinical antibody-drug conjugates (ADCs) recently acquired from LegoChem Biosciences